Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Vulvovaginal Candidiasis | Research

Recurrent Vulvovaginal Candidiasis: Assessing the relationship between feminine/vaginal washes and other factors among Ghanaian women

Authors: Emmanuel Otoo-Annan, Vivian Efua Senoo-Dogbey

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Introduction

Vulvovaginal Candidiasis (VVC) is a public health problem, with approximately 30–50% of women affected at least once during their lifetime. Recurrent Vulvovaginal Candidiasis (RVVC) is diagnosed following three or four repeated episodes of VVC in a calendar year. This condition poses health concerns with significant impacts on the quality of life of women. This cross-sectional study estimated the prevalence of RVVC and assessed the relationship between feminine/vaginal washes and other factors on RVVC among Ghanaian women in the Sekondi/Takoradi Metropolis.

Methodology

A cross-sectional study was employed to gather data from 304 women. Data were collected using a pretested questionnaire. Bivariate and multivariate analyses, including chi-square/Fisher’s exact test and logistic regression, were performed using Jamovi (R Core Team 2021) software. Proportions were calculated, and odds ratios and their corresponding 95% confidence intervals were computed with the level of significance set at 0.05.

Results

The prevalence of RVVC was estimated as 48.4% (95% CI 42.6%, 54.1%). Feminine Vaginal wash use (aOR = 3.86; 95% CI = 2.18, 6.84); age 36–45 years (aOR = 0.36; 95% CI = 0.17, 0.76) marital status (aOR = 2.37; 95% CI = 1.17, 4.79) and Sexual activity (aOR:0.43: 95%CI = 0.21, 0.88) were significantly associated with RVVC with p < 0.005.

Conclusion

RVVC is prevalent among women in the Sekondi/Takoradi Metropolis of Ghana. Feminine/Vaginal washes could be cautiously linked to the development of RVVC.
Literature
1.
go back to reference Yano J, Sobel JD, Nyirjesy P, Sobel R, Williams VL, Yu Q, et al. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Womens Health. 2019;19(1):1–9.CrossRef Yano J, Sobel JD, Nyirjesy P, Sobel R, Williams VL, Yu Q, et al. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Womens Health. 2019;19(1):1–9.CrossRef
2.
go back to reference Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Reports. 2021;70(4):1–187.CrossRef Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Reports. 2021;70(4):1–187.CrossRef
3.
go back to reference Aballéa S, Guelfucci F, Wagner J, Khemiri A, Dietz JP, Sobel J, et al. Subjective health status and health-related quality of life among women with recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA. Health Qual Life Outcomes. 2013;11(1):1–13.CrossRef Aballéa S, Guelfucci F, Wagner J, Khemiri A, Dietz JP, Sobel J, et al. Subjective health status and health-related quality of life among women with recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA. Health Qual Life Outcomes. 2013;11(1):1–13.CrossRef
5.
go back to reference Pesewu GA, Feglo PK, Boateng RK, Fayemiwo SA. Prevalence and antifungal susceptibility pattern of candida 1 solates from women with recurrent vulvovaginal candidiasis in Ghana:a review of laboratory reports. Res Square. 2020. p. 1–24. Pesewu GA, Feglo PK, Boateng RK, Fayemiwo SA. Prevalence and antifungal susceptibility pattern of candida 1 solates from women with recurrent vulvovaginal candidiasis in Ghana:a review of laboratory reports. Res Square. 2020. p. 1–24.
6.
go back to reference Rosati D, Bruno M, Jaeger M, Ten Oever J, Netea MG. Recurrent vulvovaginal candidiasis: an immunological perspective. Microorganisms. 2020;8(2):1–14.CrossRef Rosati D, Bruno M, Jaeger M, Ten Oever J, Netea MG. Recurrent vulvovaginal candidiasis: an immunological perspective. Microorganisms. 2020;8(2):1–14.CrossRef
7.
go back to reference Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018;18(11):e339–47.CrossRefPubMed Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018;18(11):e339–47.CrossRefPubMed
8.
go back to reference Moshfeghy Z, Tahari S, Janghorban R, Najib FS, Mani A, Sayadi M. Association of sexual function and psychological symptoms including depression, anxiety and stress in women with recurrent vulvovaginal candidiasis. Vol. 21, Journal of the Turkish German Gynecology Association. 2020. p. 90–6. Moshfeghy Z, Tahari S, Janghorban R, Najib FS, Mani A, Sayadi M. Association of sexual function and psychological symptoms including depression, anxiety and stress in women with recurrent vulvovaginal candidiasis. Vol. 21, Journal of the Turkish German Gynecology Association. 2020. p. 90–6.
9.
go back to reference Rasti S, Asadi MA, Taghriri A, Behrashi M, Mousavie G. Vaginal candidiasis complications on pregnant women. Jundishapur J Microbiol. 2014;7(2):1–2.CrossRef Rasti S, Asadi MA, Taghriri A, Behrashi M, Mousavie G. Vaginal candidiasis complications on pregnant women. Jundishapur J Microbiol. 2014;7(2):1–2.CrossRef
11.
go back to reference Pesewu GA, Feglo PK, Boateng RK, Fayemiwo SA. Prevalence and Antifungal Susceptibility Pattern of Candida isolates from women with recurrent Vulvovaginal Candidiasis in Ghana - A Review of Laboratory Reports. Res Sq. 2020;1–24. Pesewu GA, Feglo PK, Boateng RK, Fayemiwo SA. Prevalence and Antifungal Susceptibility Pattern of Candida isolates from women with recurrent Vulvovaginal Candidiasis in Ghana - A Review of Laboratory Reports. Res Sq. 2020;1–24.
12.
go back to reference Ocansey BK, Pesewu GA, Codjoe FS, Osei-Djarbeng S, Feglo PK, Denning DW. Estimated burden of serious fungal infections in Ghana. J Fungi. 2019;5(2):1–15.CrossRef Ocansey BK, Pesewu GA, Codjoe FS, Osei-Djarbeng S, Feglo PK, Denning DW. Estimated burden of serious fungal infections in Ghana. J Fungi. 2019;5(2):1–15.CrossRef
13.
go back to reference Ziba FA, Yakong VN, Asore RA, Frederickson K, Flynch M. Douching practices among women in the Bolgatanga municipality of the upper east region of Ghana. BMC Womens Health. 2019;19(1):1–5.CrossRef Ziba FA, Yakong VN, Asore RA, Frederickson K, Flynch M. Douching practices among women in the Bolgatanga municipality of the upper east region of Ghana. BMC Womens Health. 2019;19(1):1–5.CrossRef
14.
go back to reference Adjapong G, Hale M, Garrill A. A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana. Med Mycol. 2017;55(6):686–9.PubMed Adjapong G, Hale M, Garrill A. A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana. Med Mycol. 2017;55(6):686–9.PubMed
15.
go back to reference Martino J, Vermund S. Vaginal douching: evidence for risks or benefits to women’s Health. Epidemiol Rev. 2002;24(2):109–24.CrossRefPubMed Martino J, Vermund S. Vaginal douching: evidence for risks or benefits to women’s Health. Epidemiol Rev. 2002;24(2):109–24.CrossRefPubMed
16.
go back to reference Djohan V, Angora KE, Vanga-Bosson AH, Konaté A, Kassi KF, Kiki-Barro PCM, et al. Recurrent vulvo-vaginal candidiasis in Abidjan (Côte d’Ivoire): Aetiology and associated factors. J Mycol Med. 2019;29(2):127–31.CrossRefPubMed Djohan V, Angora KE, Vanga-Bosson AH, Konaté A, Kassi KF, Kiki-Barro PCM, et al. Recurrent vulvo-vaginal candidiasis in Abidjan (Côte d’Ivoire): Aetiology and associated factors. J Mycol Med. 2019;29(2):127–31.CrossRefPubMed
18.
go back to reference González FU, Gutiérrez HR, Méndez MJD. Recurrent vulvovaginal candidiasis. Rev Médica Sinerg. 2021;6(9). González FU, Gutiérrez HR, Méndez MJD. Recurrent vulvovaginal candidiasis. Rev Médica Sinerg. 2021;6(9).
19.
go back to reference Sobel JD. New antifungals for vulvovaginal candidiasis: what is their olre? Clin Infect Dis. 2023;76(5):783–5.CrossRefPubMed Sobel JD. New antifungals for vulvovaginal candidiasis: what is their olre? Clin Infect Dis. 2023;76(5):783–5.CrossRefPubMed
20.
go back to reference Farr A, Effendy I, Tirri BF, Hof H, Mayser P, Petricevic L, et al. Vulvovaginal candidosis (excluding mucocutaneous candidosis): Guideline of the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) Society of Gynecology and Obstetrics. Geburtshilfe Frauenheilkd. 2021;81(4):398–421. Farr A, Effendy I, Tirri BF, Hof H, Mayser P, Petricevic L, et al. Vulvovaginal candidosis (excluding mucocutaneous candidosis): Guideline of the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) Society of Gynecology and Obstetrics. Geburtshilfe Frauenheilkd. 2021;81(4):398–421.
21.
go back to reference Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2015;62(4):e1–50. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2015;62(4):e1–50.
22.
go back to reference Sherrard J, Wilson J, Donders G, Mendling W, Jensen JS. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organization (WHO) guideline on the management of vaginal discharge. Int J STD AIDS. 2018;29(13):1258–72. Sherrard J, Wilson J, Donders G, Mendling W, Jensen JS. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organization (WHO) guideline on the management of vaginal discharge. Int J STD AIDS. 2018;29(13):1258–72.
23.
go back to reference Foxman B, Muraglia R, Dietz JP, Sobel JD, Wagner J. Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. J Low Genit Tract Dis. 2013;17(3):340–5.CrossRefPubMed Foxman B, Muraglia R, Dietz JP, Sobel JD, Wagner J. Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. J Low Genit Tract Dis. 2013;17(3):340–5.CrossRefPubMed
26.
go back to reference Oh MK, Merchant JS, Brown P. Douching behavior in high-risk adolescents: what do they use, when and why do they douche? J Pediatr Adolesc Gynecol. 2002;15(2):83–8.CrossRefPubMed Oh MK, Merchant JS, Brown P. Douching behavior in high-risk adolescents: what do they use, when and why do they douche? J Pediatr Adolesc Gynecol. 2002;15(2):83–8.CrossRefPubMed
27.
go back to reference Suwanrattanadech S, Lertbunnaphong T, Boriboonhirunsarn D. Use of feminine hygiene products in Thai women. Siriraj Med J. 2011;63(4):2009–12. Suwanrattanadech S, Lertbunnaphong T, Boriboonhirunsarn D. Use of feminine hygiene products in Thai women. Siriraj Med J. 2011;63(4):2009–12.
28.
go back to reference Hull T, Hilber AM, Chersich MF, Bagnol B, Prohmmo A, Smit JA, et al. Prevalence, motivations, and adverse effects of vaginal practices in Africa and Asia: findings from a multicountry household survey. J Women’s Health. 2011;20:1097–109.CrossRef Hull T, Hilber AM, Chersich MF, Bagnol B, Prohmmo A, Smit JA, et al. Prevalence, motivations, and adverse effects of vaginal practices in Africa and Asia: findings from a multicountry household survey. J Women’s Health. 2011;20:1097–109.CrossRef
29.
go back to reference Yang W, Nie Y, Wang S, Wang H, Zhao E, Dou N. Previous antibiotic treatment as a risk factor for recurrent vulvovaginal candidiasis. Clin J Obstet Gynecol. 2019;2(2):127–32.CrossRef Yang W, Nie Y, Wang S, Wang H, Zhao E, Dou N. Previous antibiotic treatment as a risk factor for recurrent vulvovaginal candidiasis. Clin J Obstet Gynecol. 2019;2(2):127–32.CrossRef
31.
go back to reference McClelland RS, Lavreys L, Hassan WM, Mandaliya K, Ndinya-Achola JO, Baeten JM. Vaginal washing and increased risk of HIV-1 acquisition among African women: a 10-year prospective study. AIDS. 2006;20(2):269–73.CrossRefPubMed McClelland RS, Lavreys L, Hassan WM, Mandaliya K, Ndinya-Achola JO, Baeten JM. Vaginal washing and increased risk of HIV-1 acquisition among African women: a 10-year prospective study. AIDS. 2006;20(2):269–73.CrossRefPubMed
32.
go back to reference Nicole W. A question for women’s health:chemicals in feminine hygiene products and personal lubricants. Environ Heal Perspect. 2014;122(3). Nicole W. A question for women’s health:chemicals in feminine hygiene products and personal lubricants. Environ Heal Perspect. 2014;122(3).
33.
Metadata
Title
Recurrent Vulvovaginal Candidiasis: Assessing the relationship between feminine/vaginal washes and other factors among Ghanaian women
Authors
Emmanuel Otoo-Annan
Vivian Efua Senoo-Dogbey
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-17668-x

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue